Unite Acquisition 1 net loss widens 90% to $1.15 million in Q1 FY26

ADAPTIN BIO INC.

ADAPTIN BIO INC.

APTN

0.00
  • Unite Acquisition 1 posted a net loss of USD 1.15 million for the quarter ended March 31, 2026, widening 90% from the prior-year period.
  • Operating loss widened 35% to USD 1.14 million as total operating expenses climbed 35% to USD 1.14 million.
  • Research and development costs more than doubled to USD 165,577, while general and administrative expense rose 24% to USD 978,576.
  • Cash and cash equivalents fell to USD 301,309 at March 31, 2026 from USD 459,174 at Dec. 31, 2025, with operating cash outflow narrowing to USD 596,298.
  • Management said existing cash will not be sufficient to fund operating activities for the next 12 months, citing plans to seek additional funding through equity offerings, debt financings, or other third-party sources.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Unite Acquisition 1 Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-057188), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.